Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Related Posts
Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi[...]
Ribeiro FC, Kemmerich KK, Gonçale JC, Junqueira JC, Mannan M, Nabeela S, Colombo AL, Uppuluri P. Candida albicans recovered from persistent candidemia exhibit enhanced virulence[...]
Nelson A, Bheemraj K, Dean SS, de Voux A, Hlatshwayo L, Mvududu R, Berkowitz N, Neumuller C, Jacobs S, Fourie S, Coates T, Gail-Bekker L,[...]